HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylvia L Asa Selected Research

seocalcitol

1/2011Vitamin D inhibits CEACAM1 to promote insulin/IGF-I receptor signaling without compromising anti-proliferative action.
9/20051alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness.
10/2002Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells.
2/2002Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylvia L Asa Research Topics

Disease

106Neoplasms (Cancer)
03/2022 - 03/2002
37Pituitary Neoplasms (Pituitary Adenoma)
11/2019 - 01/2002
27Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 01/2002
21Adenoma (Adenomas)
10/2019 - 01/2002
14Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2022 - 07/2002
14Carcinoma (Carcinomatosis)
09/2021 - 01/2004
13Carcinogenesis
11/2021 - 01/2002
10Paraganglioma (Paragangliomas)
03/2022 - 01/2009
10Acromegaly
01/2021 - 11/2005
7Pheochromocytoma
01/2021 - 01/2009
7Papillary Thyroid Cancer
01/2021 - 04/2002
7Neoplasm Metastasis (Metastasis)
01/2019 - 03/2005
6Pituitary ACTH Hypersecretion
01/2021 - 01/2002
6Hyperplasia
01/2019 - 10/2002
6Breast Neoplasms (Breast Cancer)
01/2018 - 10/2008
6Melanoma (Melanoma, Malignant)
12/2010 - 08/2007
5Parathyroid Neoplasms (Parathyroid Neoplasm)
10/2019 - 11/2002
5Hypoxia (Hypoxemia)
01/2018 - 01/2009
4Hyperprolactinemia
01/2021 - 07/2006
4Inflammation (Inflammations)
10/2019 - 02/2006
4Papillary Carcinoma
01/2019 - 05/2010
4Thyroid Nodule (Nodule, Thyroid)
01/2018 - 03/2008
4Multiple Endocrine Neoplasia Type 1
02/2016 - 10/2005
4Lymphatic Metastasis
03/2008 - 03/2002
3Ganglioneuroma
03/2022 - 01/2008
3Adrenocortical Adenoma (Disease, Conn's)
09/2020 - 01/2009
3Adrenocortical Carcinoma
06/2018 - 06/2009
3Neuroendocrine Carcinoma
04/2017 - 01/2009
3Cushing Syndrome
03/2013 - 01/2002
3Testicular Neoplasms (Testicular Cancer)
06/2009 - 08/2007
2Craniopharyngioma (Craniopharyngiomas)
03/2021 - 01/2018
2Necrosis
01/2021 - 10/2010
2Hypercalcemia (Milk Alkali Syndrome)
01/2019 - 01/2018
2Neurocytoma
01/2019 - 01/2019
2Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
01/2019 - 04/2017

Drug/Important Bio-Agent (IBA)

29Hormones (Hormone)IBA
03/2022 - 07/2002
19Proteins (Proteins, Gene)FDA Link
11/2021 - 10/2002
17Biomarkers (Surrogate Marker)IBA
03/2022 - 10/2012
16Protein Isoforms (Isoforms)IBA
01/2017 - 01/2002
14Adrenocorticotropic Hormone (ACTH)FDA Link
03/2019 - 01/2002
11Growth Hormone (Somatotropin)IBA
05/2021 - 04/2005
10Keratins (Keratin)IBA
03/2022 - 03/2005
10Transcription Factors (Transcription Factor)IBA
12/2021 - 01/2002
10Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2012 - 09/2003
9Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
11/2012 - 03/2005
8Biological ProductsIBA
03/2022 - 03/2002
8ProlactinIBA
05/2021 - 04/2004
8DNA (Deoxyribonucleic Acid)IBA
01/2016 - 09/2003
7Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2018 - 11/2005
6GlucocorticoidsIBA
01/2021 - 04/2005
6Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
01/2018 - 06/2007
6AntigensIBA
01/2016 - 08/2007
6Messenger RNA (mRNA)IBA
12/2015 - 04/2005
5Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2021 - 01/2014
5Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
03/2019 - 11/2008
5Type 4 Fibroblast Growth Factor ReceptorIBA
06/2013 - 05/2003
5Histones (Histone)IBA
09/2009 - 09/2003
4CatecholaminesIBA
03/2022 - 09/2003
4IodineIBA
01/2021 - 07/2003
4Sunitinib (Sutent)FDA Link
01/2019 - 01/2009
4AntibodiesIBA
06/2018 - 03/2008
4Insulin (Novolin)FDA Link
03/2018 - 02/2006
4Pro-Opiomelanocortin (Proopiomelanocortin)IBA
12/2015 - 01/2002
4Hydrocortisone (Cortisol)FDA LinkGeneric
01/2015 - 01/2002
4Cyclin D1IBA
08/2014 - 04/2002
4seocalcitolIBA
01/2011 - 02/2002
4Cadherins (E-Cadherin)IBA
03/2008 - 10/2004
3ThyroglobulinFDA Link
09/2021 - 12/2004
3CollagenIBA
10/2020 - 09/2015
3Octreotide (Sandostatin)FDA LinkGeneric
03/2019 - 01/2009
3CalciumIBA
01/2019 - 11/2002
3Somatostatin Receptors (Somatostatin Receptor)IBA
01/2019 - 01/2002
3C-terminal binding proteinIBA
01/2018 - 03/2012
3Tyrosine Kinase InhibitorsIBA
08/2014 - 02/2005
3Matrix Metalloproteinases (MMPs)IBA
12/2013 - 10/2012
3OsteopontinIBA
12/2013 - 06/2009
3Corticotropin-Releasing HormoneIBA
03/2013 - 01/2002
3Fibronectins (Fibronectin)IBA
04/2012 - 09/2005
3Vitamin DFDA LinkGeneric
01/2011 - 02/2002
3CEACAM1 ProteinIBA
01/2011 - 07/2009
3Cholecalciferol (Vitamin D3)FDA Link
01/2011 - 02/2002
3Complementary DNA (cDNA)IBA
04/2008 - 10/2004
3PD 173074IBA
11/2006 - 02/2005
2Norepinephrine (Noradrenaline)FDA LinkGeneric
03/2022 - 08/2014
2EnzymesIBA
03/2022 - 09/2003
2Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
03/2022 - 09/2014
2Thyroid HormonesIBA
11/2021 - 06/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2021 - 02/2006
2Complement System Proteins (Complement)IBA
06/2021 - 01/2021
2MicroRNAs (MicroRNA)IBA
03/2021 - 03/2009
2Mitochondrial DNA (mtDNA)IBA
01/2021 - 03/2010
2beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
01/2020 - 10/2004
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2019 - 12/2012
2Sorafenib (BAY 43-9006)FDA Link
01/2019 - 01/2018
2LigandsIBA
01/2019 - 10/2004
2Vasopressins (Vasopressin)IBA
01/2019 - 03/2018

Therapy/Procedure

26Therapeutics
03/2021 - 01/2002
8Radiotherapy
01/2021 - 01/2002
4Thyroidectomy
01/2019 - 07/2003
3Drug Therapy (Chemotherapy)
08/2021 - 12/2006